<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Opioid toxicity / Respiratory arrest - ACLS - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Opioid toxicity</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../acls.html">Back to ACLS</a>
        <a class="btn small" href="../../acls_special.html">Back to Special Situations</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">ACLS Special Situation</div>
      <h1>Opioid toxicity / Respiratory arrest</h1>

      <div class="content">
        <h2>Entry criteria (suspect opioid tox)</h2>
        <ul>
          <li>Depressed level of consciousness with respiratory depression or apnea</li>
          <li>May have: miosis, bradypnea, hypoxemia, cyanosis</li>
          <li>Consider mixed/unknown ingestion if atypical features (agitation, seizures, hyperthermia) or poor response to naloxone</li>
        </ul>

        <h2>Immediate actions (first moments)</h2>
        <ul>
          <li>Call for help; assign roles</li>
          <li>Airway/Breathing:
            <ul>
              <li>Open airway; suction as needed</li>
              <li>Provide high-flow oxygen as needed</li>
              <li>Ventilate with BVM immediately if bradypneic or apneic</li>
              <li>Apply waveform capnography if available (especially once ventilating)</li>
            </ul>
          </li>
          <li>Circulation:
            <ul>
              <li>Check pulse, BP; attach monitor/defib</li>
              <li>Establish IV access (IO if needed)</li>
            </ul>
          </li>
        </ul>

        <h2>Core approach (treat the breathing first)</h2>
        <h3>1) Ventilate/oxygenate</h3>
        <ul>
          <li>If apnea or inadequate respirations: BVM ventilation is priority</li>
          <li>Avoid hyperventilation; aim for visible chest rise and improving oxygenation/ETCO₂</li>
        </ul>

        <h3>2) Naloxone (to restore adequate breathing)</h3>
        <ul>
          <li>Goal: adequate spontaneous ventilation (not full arousal)</li>
          <li>Preferred route depends on what you can do quickly (IV/IO vs IM vs IN)</li>
          <li>Adult dosing (VERIFY your local protocol and product concentration):
            <ul>
              <li>If IV/IO available:
                <ul>
                  <li>Titrate in small increments to effect (e.g., 0.04 mg → 0.1 mg → 0.2 mg → 0.4 mg, repeating as needed)</li>
                </ul>
              </li>
              <li>If no IV/IO:
                <ul>
                  <li>IM or IN naloxone per product/device instructions (common IN kits are 4 mg per spray; IM auto-injector dosing varies)</li>
                </ul>
              </li>
            </ul>
          </li>
          <li>If no response after appropriate doses:
            <ul>
              <li>Continue ventilation and broaden differential (mixed tox, CNS event, metabolic cause)</li>
            </ul>
          </li>
        </ul>

        <h3>3) Reassess continuously</h3>
        <ul>
          <li>Respiratory rate, SpO₂, ETCO₂, mental status, airway protection</li>
          <li>Re-dose naloxone if respiratory depression recurs (naloxone may wear off before the opioid)</li>
        </ul>

        <h2>Airway/ventilation checkpoints</h2>
        <ul>
          <li>If patient cannot maintain airway, has recurrent apnea, or needs repeated naloxone:
            <ul>
              <li>Prepare for advanced airway based on your capability and context</li>
            </ul>
          </li>
          <li>If advanced airway placed:
            <ul>
              <li>Confirm with waveform capnography</li>
              <li>Maintain appropriate ventilation; monitor ETCO₂</li>
            </ul>
          </li>
        </ul>

        <h2>Complications / cautions</h2>
        <ul>
          <li>Acute withdrawal can occur (agitation, vomiting, hypertension, tachycardia)
            <ul>
              <li>Titrate naloxone to breathing, not wakefulness</li>
              <li>Be ready for aspiration risk; position and suction</li>
            </ul>
          </li>
          <li>Consider co-ingestants (benzodiazepines, alcohol, stimulants) if incomplete response</li>
        </ul>

        <h2>Exit paths</h2>
        <ul>
          <li>Improved and stable with adequate ventilation → observe for recurrence; plan disposition and follow-up</li>
          <li>Recurrent respiratory depression → repeat naloxone and consider infusion per local protocol (VERIFY)</li>
          <li>Cardiac arrest → begin ACLS arrest algorithm (treat as arrest; naloxone should not delay CPR/defib)</li>
        </ul>
      </div>
    </section>
  </main>
</body>
</html>
